Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase I/II, Randomized, Double-blind, Sham Control Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Ascending Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gen
Sponsored by UniQure
Active
$1.1M Funding
1 People
External
Related Topics
gene therapy,
neurodegenerative diseases,
clinical trial,
genetic disorders,
drug safety
People
Kirsten Anderson
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator IV
